- Home
- DNUT vs CRMD Comparison
DNUT vs CRMD Comparison
Compare DNUT & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNUT
- CRMD
- Stock Information
- Founded
- DNUT 1937
- CRMD 2006
- Country
- DNUT United States
- CRMD United States
- Employees
- DNUT N/A
- CRMD N/A
- Industry
- DNUT Food Chains
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- DNUT Consumer Staples
- CRMD Health Care
- Exchange
- DNUT Nasdaq
- CRMD Nasdaq
- Market Cap
- DNUT 720.4M
- CRMD 645.0M
- IPO Year
- DNUT 2021
- CRMD 2010
- Fundamental
- Price
- DNUT $4.15
- CRMD $7.67
- Analyst Decision
- DNUT Buy
- CRMD Strong Buy
- Analyst Count
- DNUT 7
- CRMD 6
- Target Price
- DNUT $12.29
- CRMD $14.50
- AVG Volume (30 Days)
- DNUT 3.6M
- CRMD 2.6M
- Earning Date
- DNUT 05-08-2025
- CRMD 05-08-2025
- Dividend Yield
- DNUT 3.52%
- CRMD N/A
- EPS Growth
- DNUT N/A
- CRMD N/A
- EPS
- DNUT 0.02
- CRMD N/A
- Revenue
- DNUT $1,665,397,000.00
- CRMD $43,472,170.00
- Revenue This Year
- DNUT N/A
- CRMD $207.65
- Revenue Next Year
- DNUT $11.91
- CRMD $50.13
- P/E Ratio
- DNUT $231.46
- CRMD N/A
- Revenue Growth
- DNUT N/A
- CRMD N/A
- 52 Week Low
- DNUT $3.91
- CRMD $3.61
- 52 Week High
- DNUT $14.10
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- DNUT 32.03
- CRMD 47.85
- Support Level
- DNUT $3.91
- CRMD $6.32
- Resistance Level
- DNUT $4.37
- CRMD $7.71
- Average True Range (ATR)
- DNUT 0.32
- CRMD 0.47
- MACD
- DNUT 0.04
- CRMD 0.23
- Stochastic Oscillator
- DNUT 21.52
- CRMD 92.41
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.